This study was performed on 317 patients attended to pediatric and ENT-Outpatient Clinics at Al-Azhar University Hospital of Assiut during 2 years from 2009-2011, samples were collected from middle ear fluid, 161 patients were males and 156 were females, patients were of different ages ranges from 6 months to 75 years old, children under 10 years represented 53.3% (169) of total patients in this study. The objectives were to determine the macrolide resistance of isolated Strept. pneumoniae. Out of the 317 cases of otitis media, 78 isolates of Strept. pneumoniae were obtained (24.6%). Out of them 66 isolates were from 196 cases of acute otitis media (33.7%) and 12 isolates were from 121 cases of chronic otitis media (9.9%). There were 45 isolates from males, while 33 were from females. Most isolates were taken from patients under 10 years old (51 isolates). Sensitivity pattern of Streptococcus pneumonia showed that 30. 7%, 26.9% and 24.4% were resistant to erythromycin, clarithromycin and azithromycin respectively. As previous findings proved that pneumococci resistant to erythromycin have mainly one or both distinct resistance determinants either erm(B) or mef(E). PCR was done to detect these genes in isolates (24) erythromycin resistance, it was observed that 33.3% harbored mef genes, 8.3% erm genes and 41.6% both mef and erm genes. erm B & mef E genes were detected using agarose gel electrophoresis at 224 and 347 bp respectively.
INTRODUCTION
Streptococcus pneumoniae has remained an extremely important human bacterial pathogen. Worldwide, Strept. Pneumoniae remains the most common cause of community-acquired pneumonia, bacterial meningitis, bacteremia, sinusitis, septic arthritis, osteomyelitis, peritonitis, endocarditis and otitis media, otitis media often occurs secondary to respiratory infections and is mostly caused by bacterial and viral infections that start in the nasopharynx and rapidly spread through to the Eustachian tube and the middle ear cavity, Strept. pneumoniae accounts for 30-40% of lower respiratory tract infections 1&2 . It has been reported that this organism causes more than 1 million deaths annually worldwide especially in children less than 5 years of age, mostly in the developing countries 3 . Strept. pneumoniae infections remain a serious problem in both developed and developing countries 4 .
The wide spread of antibiotic resistance of Strept. pneumoniae maybe due to that they asymptomatically colonize the nasopharynx of up to 60% of healthy children and 30% of health by adults 5 . Children typically acquire a succession of serotypes early in life and are the important source for transmission to vulnerable population 6 . Rates of asymptomatic carriage vary with age, environment and the presence of upper respiratory infections 7 . A range of environmental factors such as day care, season of year, older siblings, parental smoking, housing/crowding and breast feeding influence an individual's level of pathogen exposure and immunity 8 .
During the last decade, the clinical management of respiratory infections has become worldwide increasingly complicated by the emergence and spread of resistance in Strept. pneumoniae to commonly used antibacterial drugs, particularly β-lactams and macrolides, Data from USA showed an overall pneumococcal macrolide (erythromycin) resistance rate of 31.0% in 2000 and 2001 9 .
Macrolide resistance in Strept.. pneumoniae is mediated by 2 major mechanisms: methylation of ribosomal macrolide target sites, encoded by the erm(B) gene and drug efflux, encoded by mef(E) 1 .
The objective of polymerase chain reaction is being a powerful method for in-vitro DNA synthesis. Large amounts of a specific segment of DNA, of defined length and sequence can be synthesized from a small amount of template. PCR is a rapid, sensitive and inexpensive procedure for amplifying DNA of specific interest 10 . The principle of PCR using specific primers is used to detect the mef E and erm genes in Strept. pneumoniae strains. The primers for mef E and erm B genes are designed. Oligonucleotide pairs are designed to hybridize erm B and mef E genes from pathogenic species with resistance against erythromycin 11 .
This work was planned to estimate the percentage of Strept. pneumoniae infection among cases of acute or chronic otitis media, to determine the percentage of Strept. pneumoniae resistant to erythromycin and some macrolides from patients attending to pediatric and ENT. Department at Al Azhar university in Assiut, to determine the antibiotic susceptibility profile of erythromycin-resistant Strept. pneumoniae and detect the erm(B)and mef(E)-mediated erythromycinresistant Strept. pneumoniae.
MATERIAL AND METHODS
This study was conducted on 317 patients of different ages ranging from 6 months to 75 years old. They had otitis media and were presented to peadiatric and ENT departments at Assiut university and Al-Azhar University Hospitals. 161 patients were males and 156 were females, patients were of different age range from 6 months to 75 years old.
Samples were processed at the Laboratory of the department of microbiology and immunology, faculty of medicine, Assiut University.
Sample collection
Middle ear fluid from suspected cases of acute otitis media (AOM) or chronic otitis media (COM) was collected using sterile swabs and containers supplemented with Amies transport media.
Identification of Strept. pneumoniae
The otitis media samples were cultured on blood agar, Strept. pneumoniae were identified by basic laboratory methods including colony morphology, the α-haemolysis, Gram staining and susceptibility to Optochin (Oxoid, UK).
Antimicrobial susceptibility testing by disc diffusion method according Clinical and Laboratory Standards Institute (CLSI, 2003)
The following antibiotics were used (Oxoid, UK) erythromycin (30 µg), azithromycin (15 µg), clarithromycin (15 µg), ampicillin (30 µg), amoxicillin-clavulanate (30 µg), ceftazidime (30 µg), cefotaxime (30 µg), ceftizoxime (30 µg), cefazolin (25 µg), cefoperazone (75 µg), ciprofloxacin (5 µg), enrofloxacin (5 µg), gentamicin (10 µg), apramycin (15 µg), clindamycin (30 µg), tetracycline (30 µg) and doxycycline (30 µg).
Determination of Minimal inhibitory concentration (MIC) by E-test
Strept. pneumoniae resistant to erythromycin, azithromycin, clarithromycin were further tested by E-tests (bioMérieux, Germany). The results interpreted resistant if MIC range of erythromycin (3-64 µg/ml), for clarithromycin (2-32 µg/ml) and for azithromycin (4-64 µg/ml)
Detection of Erythromycin Resistance Genes
The total DNA was extracted from all isolates using the DNA extraction Kit (QIAamp DNA mini kit, Qiagen, Germany). Polymerase chain reactions were used to amplify two macrolide resistance encoding genes: erm(B) and mef(E)using specific primers.
Primers (VBC Genomics, Germany): For detection of
erm B gene: PCR amplicon size were compared with 100-1000 bp molecular weight DNA ladder (Pharmacia Bioron,USA).
RESULTS AND DISCUSSION

Percentage of Strept. pneumoniae among cases of acute and chronic otitis media
Out of the 317 cases of otitis media, 78 isolates of Streptococcus pneumonia were obtained (24.6%). Sixty six isolates were obtained from 196 cases of acute otitis media (33.7%) and 12 isolates were obtained from 121 cases of chronic otitis media (9.9%)
Relationship of age and sex of patients to incidence of Streptococcus pneumoniae in otitis media
Of the total 78 Strept. pneumoniae strains isolated in this work, 51 strains (65.4%) were isolated from patients under 10 years old, 20 (25.6%) from patients between over 10-20 years old, 1 (1.3%) from patients between over 20-30 years old, 1 (1.3%) from patients between over 30-40 years old, 3 (3.8%) from patients between over 40-50 years old and 2 (2.6%) from patients over 51 years. Regarding sex, 161 patients (50.8%) were males and 156 patients (49.2%) were females.. Of the total 78 Strept. pneumoniae isolates 33 (42.3%) were recovered from males, while 45(57.7%) were from females as in table 1.
Antibiotic sensitivity pattern of Streptococcus pneumoniae using disc agar diffusion method
The in-vitro sensitivity of 78 Streptococcus pneumoniae isolates to different antibiotics is shown in figure 1 and table 2. 
E-test method for determination of MIC of macrolides for preliminary erythromycin resistant Streptococcus pneumoniae (Table 3) PCR for detection of resistant determinants genes (mef E and erm B) in erythromycinresistant Strept. pneumoniae (n= 24)
Results of PCR showed that erm B & mef E genes were detected at 224 and 347 bp respectively as in figure 2. Ten cases (41.6%) showed both erm B & mef E genes, while 8 cases (33.3%) showed mef gene only and 2 cases (8.3%) showed erm gene only as in table 4. Table 5 showed that both erm and mef genes were detected in strains with MICs of ≥ 24 µg/ml to ≥ 64 µg/ml. Otitis media is the most prominent reason for antimicrobial use in a pediatric population, but the role of antibiotics in the treatment of this disease has remained controversial and a global trend of increasing antimicrobial resistance, with wide variations at national levels is well documented. Strong evidence supports an association between antibiotic use and resistance 12. Since erythromycin resistance was first detected in 1967 in USA, macrolide resistance has been increasing globally with increased use of this antibiotic 1. An increase in macrolide resistance is associated with an increase in macrolide use 13. This study aimed to estimate the incidence of Strept. pneumoniae among otitis media cases, to perform the antimicrobial sensitivity test isolates, to determine the resistance to erythromycin and some macrolides (clarithromycin and azithromycin) and to detect the frequency of common marolide resistant genes(The mef E and erm B genes) among macrolide resistant isolates by PCR technique.
Samples were collected from middle ear fluid from 317 cases representing multiple ages and both sexes, who were enrolled from the outpatient clinics of Al-Azhar hospital in Assiut.
Out of the 317 cases of otitis media, 78 isolates of Streptococcus pneumoniae were obtained (24.6%). Of the total 78 Strept. pneumoniae strains in this work 51 strains (65.4%) were isolated from patients under 10 years old. Similar findings were reported by several studies, which evaluated young age risk factor associated with nasopharyngeal carriage of Strept. pneumoniae 14 . Concerning resistance of our isolates to macrolides; a total of 30.7%, 26.9% and 24.4% of isolates were resistant to erythromycin, clarithromycin and azithromycin respectively. The erythromycin resistance rate observed in our study is significantly higher than the resistance rate among isolates from the Netherlands (2.6%) as well as the resistance rate reported in Spain (17.1%) 15. For accurate quantitative determination of macrolide resistance, the MICs were estimated using E test. MICs range of erythromycin, clarithromycin and azithromycin isolates were (3-64 µg/ml), (2-32 µg/ml) and (4-64 µg/ml) respectively. The interpretive criteria ranges as given by the E test manufacturer refers to break points of resistant strains of Strept. pneumoniae at ≥ 1 µg/ml, ≥ 1 µg/ml. qnd ≥ 2 µg/ml for erythromycin, clarithromycin and azithromycin respectively. Therefore, it can be concluded that the erythromycin, clarithromycin and azithromycin breakpoints adjusted for our method worked well.
It has been shown that pneumococci resistant to erythromycin mainly have one or both distinct resistance determinants, erm(B) and or mef(E) 14. Detection of resistance determinants (mef E and erm B) genes in our 24 erythromycin-resistant S. pneumonia isolates by PCR showed that erm B & mef E genes were detected at 224 and 347 bp respectively. These results correlate with previous findings 16-19. Analysis of our results regarding erythromycin resistance determinants in the complete set of 24 isolates showed that 33.3% harbored the mef genes, 8.3% the erm genes and 41.6% both the mef and the erm genes. In North-American countries, the mef genes are more prevalent in Strept. pneumoniae 20&21. The mef gene was observed to be the most frequent macrolide resistance gene and is more comparable with North America and Scotland than continental Europe 20&21.
On the global level, erm(B) appears to be the most common macrolide resistance determinant in pneumococci. According to a recent study, its prevalence was 55% where as the respective figure for the mef gene was 31% 22 .
It is worth mentioning that analysis of our results showed a satisfactory relation between detection of resistance determinant genes and values of MICs of resistant strains. Detection of both genes was distinguished in resistant strains showing MICs of ≥ 24 µg/ml. for erythromycin. These findings are correlate with the results of Farrell et al. 22 , who reported that resistance determinant genes could be observed in strains resistant to erythromycin with MICs of ≥ 24 µg/ml.
Conclusion
In regard to the high prevalence of erythromycin resistance, there were nearly 30% of isolated pneumococci non susceptible to erythromycin. Therefore, care should be taken before treatment of pneumococcal infections with macrolides after susceptibility testing to avoid possible treatment failures. Results points to the importance of detection of erm(B) and mef(E) genes for epidemiological purposes to track possible presence of macrolide resistance. It has been suggested that to reduce the antimicrobial prevalence in pneumococcus, a large reduction in antimicrobial consumption is needed on the population level. To summarize controlling antimicrobial resistance, a multidisciplinary approach is therefore needed that includes continuous surveillance, education and feedback.
